AGXT2 polymorphisms were identified as risk for CAD in Asian populations (Yoshino et al., 2014; Zhou et al., 2014), and SPP2 may contribute to the atheroprotective effects of HDL (Abdel-Latif et al., 2015). This evidence concerns the gene SPP2 and coronary artery disorder.